July 11, 2022 By Haley Nagasaki
(Globe Newswire) Toronto — Producer of cannabinoid-based biopharmaceuticals, Avicanna Inc., has completed its first commercial export of cosmetics. The brand Pura Health & Wellness has now made its way to the European market as part of the company’s supply and distribution agreement with Bio-Gate AG, headquartered in Germany.
This summer, Bio-Gate is prepared to launch its portfolio of products, beginning with online distribution. It will then expand into other online, retail, and pharmacy channels across Germany, Austria, and Switzerland, during 2022.
“We are pleased to be entering the European market with our first line of branded products and to be doing so in collaboration with Bio-Gate. Both teams are excited about the launch of the skincare portfolio in the coming months and are happy to see the Pura Health and Wellness brand establish a new European foothold.” — Jens Kramer, VP of European Operations at Avicanna
Print this page
- Pure Extracts Q3 corporate update
- Cannabix Technologies takes breathalyzer tech study to southern US